Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03299556 · ClinicalTrials.gov registry record
Effect of Wearable Health Technology on Patients Treated for Chronic Pain at Geisinger Health System
A clinical trial, sponsored by Purdue Pharma.
- Completed
- Registry status
- 420
- Enrollment target
NCT03299556 is a clinical trial that has completed, run by Purdue Pharma. The registered enrollment target is 420 participants.
The verdict
NCT03299556 has completed, sponsored by Purdue Pharma.
- COMPLETED
- Registry status
- 420 participants
- Enrollment target
Study Summary
This is a proof of concept study to measure the effect of Wearable Health Technology (WHT), including the Apple Watch, iPhone, Pain App and Provider Dashboards on important clinical outcomes in patients treated for chronic pain. WHT will be tested in a group of chronic pain patients treated at a specialty pain clinic, the Geisinger Multidisciplinary Pain Program (MPP). Primary and secondary outcomes include pain, physical function, depression, pain medicine use, amount of sleep, activity levels, healthcare resource utilization and cost. The WHT will collect self-reported data on pain, pain management therapies, and medication utilization, and passively collected data on subject activity levels and sleep. Additional data will be collected on device utilization by patients and health care professionals.
Interventions
- OTHER WHT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2017-10-05 |
| Est. Completion | 2019-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03299556
The ClinicalTrials.gov registry entry for NCT03299556 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 420 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Purdue Pharma, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which WHT is the first listed.
NCT03299556 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03299556 about?
NCT03299556 is a clinical study titled "Effect of Wearable Health Technology on Patients Treated for Chronic Pain at Geisinger Health System". This is a proof of concept study to measure the effect of Wearable Health Technology (WHT), including the Apple Watch, iPhone, Pain App and Provider Dashboards on important clinical outcomes in patients treated for chronic pain. WHT will be tested in a group of chronic pain patients treated at a spe...
What is the current status of trial NCT03299556?
This trial is currently completed. The enrollment target is 420 participants. The study started on 2017-10-05. Estimated completion is 2019-11-30.
What interventions are being tested in trial NCT03299556?
The interventions under investigation include: WHT (OTHER).
Who is sponsoring clinical trial NCT03299556?
This trial is sponsored by Purdue Pharma, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.